# FDA 483 - Alabama Center for Reproductive Medicine - September 15, 2025

Source: https://www.keypedia.com/records/483/alabama-center-for-reproductive-medicine/7a7a8850-b429-4b7a-be22-8bf59c7bf9be

> FDA 483 for Alabama Center for Reproductive Medicine on September 15, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Alabama Center for Reproductive Medicine
- Inspection Date: 2025-09-15
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: The FDA inspected Alabama Center for Reproductive Medicine in Birmingham, AL, and issued a Form 483. The inspection revealed a significant lack of established and maintained procedures for screening and determining the eligibility of HCT/P donors. This included deficiencies in physical exam protocols, donor eligibility criteria, and embryo donation procedures, indicating a failure to ensure proper donor screening processes for reproductive tissues.

## Related Documents

- [483 - 2025-09-15](https://www.keypedia.com/records/483/alabama-center-for-reproductive-medicine/63385072-8a3c-466f-a4be-5ce203223cc4)

## Related Officers

- [Juanelma H. Palmer](https://www.keypedia.com/people/juanelma-h-palmer/db3e79b5-d2d4-46d8-a075-4674dbc8c3d0)

Company: https://www.keypedia.com/companies/alabama-center-for-reproductive-medicine/5e7c5db1-983f-455a-9ea7-988d1dbd3190

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea